Table 2 Percentage of growth and resistance of most frequent pathogens in blood cultures of patients in unselected departments in the Netherlands in 2017Â [23]
|  | In blood culture | Amoxicillin-clavulanic acid | Cefuroxime | Ceftriaxone | Gentamicin | Ciprofloxacin | Piperacillin-tazobactam | Amoxi-clav + gentamicin | Amoxi-clav + ciprofloxacin | Cefuroxime + gentamicin | Cefuroxime + ciprofloxacin | Ceftriaxone + gentamicin | Ceftriaxone + ciprofloxacin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
E. coli | 23% | 37% | 12% | 6% | 4% | 14% | 5% | 3% | 9% | 2% | 6% | 1% | 4% |
K. pneumoniae | 4% | 17% | 14% | 10% | 5% | 14% | 7% | 4% | 9% | 4% | 9% | 4% | 7% |
P. mirabilis | 1% | 8% | 1% | 1% | 5% | 11% | 1% | 2% | 2% | 0% | 0% | 0% | 0% |
E. cloacae | 1% | Â | Â | Â | 3% | 5% | Â | Â | Â | Â | Â | Â | Â |
Other Enterobacterales | 5% | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
P. aeruginosa | 2% | Â | Â | Â | 2% | 9% | 5% | Â | Â | Â | Â | Â | Â |
S. aureus | 10% | 1% | Â | 1% | 0% | 6% | 1% | Â | Â | Â | Â | Â | Â |
Other Gram-positives | 12% | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |